Literature DB >> 8439509

Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.

Y Kakeji1, D Korenaga, S Tsujitani, H Baba, H Anai, Y Maehara, K Sugimachi.   

Abstract

Overexpression of the tumour suppressor gene p53 was investigated immunohistochemically in 96 primary gastric carcinomas and 26 corresponding metastatic perigastric lymph nodes. Abnormalities in p53 expression were found in 52 (54%) of the 96 primary carcinomas. Tumours stained positively for p53 frequently metastasised to lymph nodes (the metastatic rate: 85%) compared to findings in those with negative p53 staining (64%, P < 0.05). Ninety-two percent (24/26) of the malignant cells in the lymph nodes stained positively for p53. When the DNA ploidy pattern of the tumour was determined by flow cytometry, the aneuploid tumours in p53 positive and negative groups accounted for 69% and 45%, respectively (P < 0.05). Proliferative activity of the tumour, as measured by Ki-67 labelling, was significantly higher (30.6 +/- 12.0%) in the p53 positive group than that (25.1 +/- 10.7%) in the p53 negative group (P < 0.05). Thus, gastric cancer with a mutant p53 has high proliferative activity and metastasis to lymph nodes will probably occur.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8439509      PMCID: PMC1968266          DOI: 10.1038/bjc.1993.108

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Inhibition of cell growth mediated by plasmids encoding p53 anti-sense.

Authors:  O Shohat; M Greenberg; D Reisman; M Oren; V Rotter
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

2.  Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.

Authors:  C A Finlay; P W Hinds; T H Tan; D Eliyahu; M Oren; A J Levine
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

3.  Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.

Authors:  J Bartek; R Iggo; J Gannon; D P Lane
Journal:  Oncogene       Date:  1990-06       Impact factor: 9.867

4.  p53 mutations in colorectal cancer.

Authors:  N R Rodrigues; A Rowan; M E Smith; I B Kerr; W F Bodmer; J V Gannon; D P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  p53 gene mutations in colorectal tumors from patients with familial polyposis coli.

Authors:  S Shirasawa; K Urabe; Y Yanagawa; K Toshitani; T Iwama; T Sasazuki
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

Review 6.  [Molecular diagnosis of gastric cancer].

Authors:  W Yasui; K Yoshida; H Ito; E Tahara
Journal:  Gan To Kagaku Ryoho       Date:  1991-01

Review 7.  Tumor suppressor genes: new prospects for cancer research.

Authors:  R E Hollingsworth; W H Lee
Journal:  J Natl Cancer Inst       Date:  1991-01-16       Impact factor: 13.506

8.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

9.  Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.

Authors:  J V Gannon; R Greaves; R Iggo; D P Lane
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

10.  p53 in colorectal cancer: clinicopathological correlation and prognostic significance.

Authors:  N Scott; P Sagar; J Stewart; G E Blair; M F Dixon; P Quirke
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

View more
  38 in total

1.  Extremely well-differentiated adenocarcinoma of the stomach: clinicopathological and immunohistochemical features.

Authors:  Takashi Yao; Takashi Utsunomiya; Masafumi Oya; Kenichi Nishiyama; Masazumi Tsuneyoshi
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

2.  TP53 gene mutations in gastric carcinoma detected by polymerase chain reaction/single-strand conformation polymorphism analysis of archival material.

Authors:  E D'Andrea; R Baffa; C Menin; M Montagna; M Rugge; L Chieco-Bianchi
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

3.  Prognostic significance of p53 protein expression in early gastric cancer.

Authors:  Andrea Rodrigues Gonçalves; Antonio Jose Vasconcellos Carneiro; Ivanir Martins; Paulo Antonio Silvestre de Faria; Maria Aparecida Ferreira; Eduardo Linhares Riello de Mello; Homero Soares Fogaça; Celeste Carvalho Siqueira Elia; Heitor Siffert Pereira de Souza
Journal:  Pathol Oncol Res       Date:  2010-11-30       Impact factor: 3.201

4.  Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma.

Authors:  M Salih Deveci; Güzin Deveci
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

5.  p53 mutations in gastric and colorectal cancers in Texas Hispanics versus Anglos.

Authors:  B G Schneider; S G Hilsenbeck; C H Hensel; V Pekkel; C H Shelton; H A Rodríguez-Martínez; M E Gutiérrez-Díaz; D R Pulitzer; D C Allred
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  Expression of p53 protein related to human papillomavirus and DNA ploidy in superficial esophageal carcinoma.

Authors:  T Nakamura; H Ide; R Eguchi; K Hayashi; F Hanyu; K Nagasako; M Yukawa; K Asaka; T Fujimori; S Maeda
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 7.  Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy.

Authors:  J A Ajani; P F Mansfield; D M Ota
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

8.  Expression of cyclooxygenase-2, p53 and Ki-67 in gastric cancer.

Authors:  Young-Eun Joo; Ik-Joo Chung; Young-Kyu Park; Yang-Seok Koh; Jae-Hyuk Lee; Chang-Hwan Park; Wan-Sik Lee; Hyun-Soo Kim; Sung-Kyu Choi; Jong-Sun Rew; Chang-Soo Park; Sei-Jong Kim
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

9.  Magnifying chromoendoscopy combined with immunohistochemical staining for early diagnosis of gastric cancer.

Authors:  Xian-Mei Meng; Yi Zhou; Tong Dang; Xu-Yang Tian; Jie Kong
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

10.  Chronology of p53 protein accumulation in gastric carcinogenesis.

Authors:  M E Craanen; P Blok; W Dekker; G J Offerhaus; G N Tytgat
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.